Home Cart Sign in  
Chemical Structure| 55778-02-4 Chemical Structure| 55778-02-4

Structure of WZ811
CAS No.: 55778-02-4

Chemical Structure| 55778-02-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WZ811 is a small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WZ811

CAS No. :55778-02-4
Formula : C18H18N4
M.W : 290.36
SMILES Code : C1(CNC2=NC=CC=C2)=CC=C(CNC3=NC=CC=C3)C=C1
MDL No. :MFCD18086914
InChI Key :KBVFRXIGQQRMEF-UHFFFAOYSA-N
Pubchem ID :11565518

Safety of WZ811

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of WZ811

GPCR

Isoform Comparison

Biological Activity

Target
  • CXCR4

    CXCR4, EC50:0.3 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
M-07e 1 µM 12 hours WZ811 significantly decreased the migration number of M-07e induced by BLM-treated lung tissues. Cell Death Dis. 2019 Sep 9;10(9):648.
Medullary thyroid carcinoma cell line TT 100 nM and 1 µM 24 hours To investigate the effect of WZ811 on the invasiveness of medullary thyroid carcinoma cells, the results showed that WZ811 significantly reduced the invasiveness of cancer cells. Br J Cancer. 2017 Dec 5;117(12):1837-1845.
Human follicular thyroid carcinoma cell line TT2609-C02 1 µM and 100 nM 24 hours Investigate the effect of WZ811 on the invasiveness of TT2609-C02 cells, results showed WZ811 significantly reduced the number of invading cells J Cancer. 2018 Feb 27;9(6):929-940.
MELHO cells 10 µM WZ811 inhibited CXCR4, reduced osteotropism, and activated mTOR and p70-S6 cell signaling proteins. Cells. 2024 Feb 27;13(5):408.
1F5 RUNX2 KO cells 1.3 µg/mL and 2.6 µg/mL Restored RUNX2 expression increased the levels of CXCR4 and proteins associated with the metastatic process. Cells. 2024 Feb 27;13(5):408.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice BLM-induced pulmonary fibrosis model Intragastric administration 4 mg/kg Once daily for 14 consecutive days WZ811 significantly attenuated BLM-induced pulmonary fibrosis, reduced the migration of CD41+ megakaryocytes, and decreased collagen deposition and TGF-β1 levels in lung tissue. Cell Death Dis. 2019 Sep 9;10(9):648.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.44mL

0.69mL

0.34mL

17.22mL

3.44mL

1.72mL

34.44mL

6.89mL

3.44mL

References

 

Historical Records

Categories